Clinical Trial Update: A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase I/IIa study of RC88-ADC in subjects with advanced malignant solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• RC88-ADC

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Solid Tumor | Phase 1, Phase 2 | Status: COMPLETED